Paul RohrichtChief Business Officer – Pharma at Nuritas Corporation
Paul Rohricht, MS MBA, is Chief Business Officer-Pharma, for Dublin-based AI drug discovery company Nuritas, and is based in Philadelphia. Prior to Nuritas, Mr. Rohricht has held senior business development positions with early-stage med tech firms including ChemImage and Symphogen, and is the co-founder of Revivicor, which was sold to United Therapeutics. He has also previously held the position of Entrepreneur-in-Residence at Wake Forest School of Medicine. He is also a US and EU patent holder, with several others pending. He is a graduate of St. Olaf College and the Wharton School of Business.